Acorda Therapeutics Inc EBIT margin
Qual é o EBIT margin de Acorda Therapeutics Inc?
O EBIT margin de Acorda Therapeutics Inc é -224.84%
Qual é a definição de EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin de empresas na Setor Health Care em NASDAQ em comparação com Acorda Therapeutics Inc
O que Acorda Therapeutics Inc faz?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Empresas com ebit margin semelhantes a Acorda Therapeutics Inc
- Accelerate Diagnostics Inc tem EBIT margin de -227.57%
- Affimed N.V tem EBIT margin de -227.50%
- Tellurian Inc tem EBIT margin de -226.66%
- Acceleron Pharma Inc tem EBIT margin de -225.99%
- Frequency Exchange tem EBIT margin de -225.62%
- WS Industries (India) tem EBIT margin de -225.31%
- Acorda Therapeutics Inc tem EBIT margin de -224.84%
- Fangdd Network Ltd tem EBIT margin de -224.41%
- DSS Inc tem EBIT margin de -224.16%
- ClearSign Technologies Corp tem EBIT margin de -222.55%
- IMP Powers tem EBIT margin de -221.89%
- COSCIENS Biopharma tem EBIT margin de -221.38%
- Escape Hunt plc tem EBIT margin de -220.51%